Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

A new era of drug safety: European pharmacovigilance

The introduction of a new law on pharmacovigilance is set to revolutionise European drug safety in years to come. In the run-up to Arena International's Pharmacovigilance, Drug Safety and Risk Management event, Elisabeth Fischer speaks to Heiko Martin, head of global drug safety at Grünenthal, about implications for detecting and preventing adverse drug reactions.

Go Top